Reply to: appropriate dosing of burosumab in tumor-induced osteomalacia.

Osteoporos Int

Department of Rheumatology, ASST-Pini-CTO, Milan, Italy.

Published: February 2023

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00198-022-06618-1DOI Listing

Publication Analysis

Top Keywords

reply appropriate
4
appropriate dosing
4
dosing burosumab
4
burosumab tumor-induced
4
tumor-induced osteomalacia
4
reply
1
dosing
1
burosumab
1
tumor-induced
1
osteomalacia
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!